4(3H)-quinazolinones with a variety of heterocyclic substituents bound
to the 6-position have been synthesized and evaluated as angiotensin
II receptor antagonists both in vitro and in vivo. Some of these compo
unds have been shown to be potent, long-lasting, orally active antihyp
ertensives.